918831-13-7 Usage
Uses
Used in Pharmaceutical Research:
3-(2-Fluoro-phenoxy)-azetidine is utilized as a key compound in pharmaceutical research for its potential biological activity. Its unique structure allows it to be a candidate for the development of new drugs, particularly in the context of medicinal chemistry where novel scaffolds are constantly sought after.
Used in Drug Development:
In the field of drug development, 3-(2-Fluoro-phenoxy)-azetidine is employed as a starting material or a building block for the synthesis of new pharmaceutical agents. Its properties may contribute to the creation of drugs with specific therapeutic targets, potentially leading to innovative treatments for various diseases.
Used in Chemical Investigations:
3-(2-Fluoro-phenoxy)-azetidine is also used as a subject of study in chemical investigations. Its distinct molecular structure provides opportunities for researchers to explore its reactivity, stability, and potential to form new chemical entities, which could be valuable in both academic and industrial settings.
Used in Medicinal Chemistry:
In medicinal chemistry, 3-(2-Fluoro-phenoxy)-azetidine is used as a scaffold for the design of new molecules with therapeutic potential. Its incorporation into drug candidates can lead to the discovery of compounds with improved pharmacokinetic and pharmacodynamic profiles, enhancing their efficacy and safety in treating medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 918831-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,8,8,3 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 918831-13:
(8*9)+(7*1)+(6*8)+(5*8)+(4*3)+(3*1)+(2*1)+(1*3)=187
187 % 10 = 7
So 918831-13-7 is a valid CAS Registry Number.
918831-13-7Relevant articles and documents
ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS
-
Page/Page column 62, (2008/12/05)
The present invention provides Stearoyl CoA Desaturase (SCD) inhibitors, hi particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase 1 (SCD 1) inhibitors. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by Stearoyl CoA Desaturase (SCD) inhibitors.
